Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Stress-related inflammation may increase risk for depression

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • Key factor in transition from moderate to problem drinking

  • Immune proteins moonlight to regulate brain-cell connections

  • Fight against Alzheimer's disease: New research on walnuts

  • Why your brain makes you reach for junk food

  • See-through sensors open new window into the brain

  • New test to help brain injury victims recover

  • Fish intake associated with boost to antidepressant response

  •